- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07851116
Tissue Sensor to Reduce the Need for Controlled Apnea During Retrograde Intrarenal Surgery (Tissue Sensor)
Retrograde intrarenal surgery is an established minimally invasive treatment for renal stones. During laser lithotripsy, respiratory motion causes the kidney, renal collecting system, and stone to move relative to the distal tip of the laser fiber. This can impair precise fiber positioning, reduce operative-field stability, and increase the risk of unintended laser exposure of the urothelium of the renal collecting system.
To reduce respiratory motion of the kidney, the surgeon may ask the anesthesiologist to temporarily pause mechanical ventilation. Controlled apnea can briefly stabilize the operative field; however, it requires interruption of ventilation and may cause oxygen desaturation, carbon dioxide accumulation, hemodynamic changes, and increased anesthetic burden.
Tissue Sensor is a technology that automatically terminates laser emission when contact between the distal tip of the laser fiber and tissue is detected. Tissue Sensor is expected to reduce the risk of unintended laser exposure of the renal collecting-system mucosa during respiratory motion of the kidney.
Greater surgeon confidence in the safety of laser activation may reduce the need to stabilize the kidney with controlled apnea. At the same time, brief automatic interruptions of laser emission may increase lithotripsy time and total operative time.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Nikita Astakhov
- Numéro de téléphone: +8 (968) 490-46-72
- E-mail: astakhov.nikita@inbox.ru
Sauvegarde des contacts de l'étude
- Nom: Vigen Malkhasyan, Doctor of Medical Sciences
- Numéro de téléphone: +79096441688
- E-mail: botkinhospital@zdrav.mos.ru
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 18 years or older.
- A single renal stone.
- An indication for elective RIRS.
- Feasibility of performing the intervention with a flexible ureteroscope.
- Recommended stone diameter on CT: 7-15 mm.
- Stone located in a calyx, a group of calyces, or the renal pelvis.
- Feasibility of TFL use.
- General anesthesia with controlled mechanical ventilation.
- No active urinary tract infection.
- Ability to undergo low-dose non-contrast CT at 1 month.
- Signed written informed consent.
Exclusion Criteria:
- Multiple stones in the study kidney.
- Complete or partial staghorn stone.
- Ipsilateral ureteral stone.
- Renal or upper urinary tract anomaly that substantially alters the anatomy.
- Horseshoe, pelvic, or ectopic kidney.
- Stone within a calyceal diverticulum.
- Ureteral stricture.
- Previous reconstructive surgery involving the study kidney or ureter.
- Active infection, obstructive pyelonephritis, or urosepsis.
- Nephrostomy drainage.
- Pregnancy.
- Severe respiratory failure or a contraindication to apnea.
- Severe cardiovascular instability.
- Inability to undergo general anesthesia.
- Combined, bilateral, or percutaneous intervention.
- Suspected upper urinary tract tumor.
- Inability to comply with the study protocol.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: patients with a single renal stone who are scheduled for elective retrograde intrarenal surger
RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording. |
RIRS will be performed using the same TFL system with Tissue Sensor deactivated. Visually confirmed contacts between the activated laser fiber and the mucosa will be recorded from the procedure video. RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Proportion of patients requiring at least one episode of controlled intraoperative apnea during laser lithotripsy.
Délai: intraoperative
|
intraoperative
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
• number of apnea episodes;
Délai: intraoperative
|
intraoperative
|
|
total apnea duration;
Délai: intraoperative
|
intraoperative
|
|
mean number of apnea episodes per patient;
Délai: intraoperative
|
intraoperative
|
|
maximum duration of a single apnea episode;
Délai: intraoperative
|
intraoperative
|
|
minimum SpO2;
Délai: intraoperative
|
intraoperative
|
|
incidence of desaturation;
Délai: intraoperative
|
intraoperative
|
|
visible laser-induced mucosal
Délai: intraoperative
|
intraoperative
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- MoscowBotkinHospital3
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .